Dr Reddy’s Lab inks licensing pact with US-based Slayback Pharma
The company has inked a licensing pact with the NewJersey-based drug firm to acquire rights in Brimonidine Tartrate Ophthalmic Solution 0.025 percent, the Hyderabad-based firm said in a statement. As…